Haematologica
HOME HELP FEEDBACK ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


Published online 5 March 2008
(Haematologica 2008, 10.3324/haematol.12070)
Copyright © 2008 by Ferrata Storti Foundation
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Odièvre, M.-H.
Right arrow Articles by Cartron, J.-P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odièvre, M.-H.
Right arrow Articles by Cartron, J.-P.
Related Collections
Right arrowRelated Article

Original Article

Modulation of erythroid adhesion receptors expression by hydroxyurea in children with sickle cell disease

Marie-Hélène Odièvre1,8, Viviane Bony7, Malika Benkerrou2, Claudine Lapouméroulie1, Corinne Alberti5, Rolande Ducrocq3, Evelyne Jacqz-Aigrain4,6, Jacques Elion1,3, Jean-Pierre Cartron7,

1 INSERM, U763, Paris, Université Paris 7-Denis Diderot, Faculté de médecine, Paris;
2 AP-HP, Hôpital Robert-Debré, Centre de la drépanocytose, Paris;
3 AP-HP, Hôpital Robert-Debré, Laboratoire de biochimie génétique, Paris;
4 AP-HP, Hôpital Robert-Debré, CIC 9202, Paris;
5 INSERM, CIE 5, Unité d’épidémiologie clinique, Paris;
6 AP-HP, Hôpital Robert-Debré, Laboratoire de pharmacologie, Paris;
7 INSERM, U665, Institut National de la Transfusion Sanguine, Paris and
8 AP-HP, Hôpital Louis-Mourier, Service de Pédiatrie, Colombes, France

Correspondence: Jean-Pierre Cartron, Dr-Sc, INSERM U665 INTS, 6 rue Alexandre Cabanel, 75015 Paris, France. E-mail: cartron{at}idf.inserm.fr

ABSTRACT

Background: We investigated adhesion receptor levels on red blood cells, reticulocytes and erythroid progenitors from children with sickle cell disease treated or not with hydroxyurea.

Design and Methods: Four groups of patients were investigated: (i) children receiving hydroxyurea for severe vaso-occlusive events (n=26); (ii) untreated children with a history of vaso-occlusive events (n=20); (iii) children with no history of vaso-occlusive events (n=28); and (iv) healthy African controls (n=27). Expression of adhesion receptors was analyzed by flow cytometry with specific mono-clonal antibodies.

Results: Reticulocytes and/or red blood cells from the children with sickle cell disease showed significantly higher expression of CD36, {alpha}4β 1, Lu/BCAM than those from controls, whatever the severity of the disease, as well as less marked increases in expression of ICAM-4, CD47 and CD147. Under hydroxyurea treatment, the expression of CD36, {alpha}4β1 and ICAM-4 (to a lesser extent) was decreased, but surprisingly the expression of Lu/BCAM (and also CD47 and CD147 to a lesser extent) was significantly increased. Alterations of levels of adhesion receptors could be recapitulated in two-phase liquid cultures of erythroid progenitors from controls and untreated children with a history of vaso-occlusive disease, grown in the absence or presence of hydroxyurea.

Conclusions: Our results suggest that hydroxyurea acts during erythroid development and modulates adhesion receptor expression and function differently, possibly by acting on gene expression and the signaling cascade leading to receptor activation.

Key words: sickle cell disease, hydroxyurea, red cell, erythroid progenitor, adhesion.


Related Article

Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease
Clarissa Johnson, Marilyn J. Telen
Haematologica 2008 93: 481-485. [Full Text] [PDF]






HOME HELP FEEDBACK ARCHIVE SUBSCRIPTIONS
Copyright © 2008 by the Ferrata Storti Foundation.